Cocaine-Induced Coronary-Artery Constriction

John J. Ambre, R. Douglas Wilkerson, Theodore D. Fraker, Peter N. Temesy-Armos, Kensuke Egashira, James P. Morgan, Louis L. Cregler, Anthony E. Folev, Richard A. Lange, Ricardo G. Cigarroa, L. David Hillis

Research output: Contribution to journalLetter

4 Citations (Scopus)

Abstract

To the Editor: The conclusion of Lange et al. (Dec. 7 issue)1 from their study of cocaine-induced coronary-artery constriction implies that they know the shape of the cocaine dose–response curve for cardiac effects. They used doses of 110 to 210 mg intranasally (which are only about 30 percent bioavailable2) and produced cocaine concentrations of 30 to 220 ng per milliliter. We have acquired noninvasive and clinical cardiac data in 30 studies of intravenous cocaine users at plasma cocaine concentrations in the range produced by recreational use. In addition to five subjects receiving 30 mg of cocaine by intravenous injection,.

Original languageEnglish
Pages (from-to)1235-1237
Number of pages3
JournalNew England Journal of Medicine
Volume322
Issue number17
DOIs
Publication statusPublished - Apr 26 1990
Externally publishedYes

Fingerprint

Cocaine
Constriction
Coronary Vessels
Intravenous Injections

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Ambre, J. J., Wilkerson, R. D., Fraker, T. D., Temesy-Armos, P. N., Egashira, K., Morgan, J. P., ... Hillis, L. D. (1990). Cocaine-Induced Coronary-Artery Constriction. New England Journal of Medicine, 322(17), 1235-1237. https://doi.org/10.1056/NEJM199004263221714

Cocaine-Induced Coronary-Artery Constriction. / Ambre, John J.; Wilkerson, R. Douglas; Fraker, Theodore D.; Temesy-Armos, Peter N.; Egashira, Kensuke; Morgan, James P.; Cregler, Louis L.; Folev, Anthony E.; Lange, Richard A.; Cigarroa, Ricardo G.; Hillis, L. David.

In: New England Journal of Medicine, Vol. 322, No. 17, 26.04.1990, p. 1235-1237.

Research output: Contribution to journalLetter

Ambre, JJ, Wilkerson, RD, Fraker, TD, Temesy-Armos, PN, Egashira, K, Morgan, JP, Cregler, LL, Folev, AE, Lange, RA, Cigarroa, RG & Hillis, LD 1990, 'Cocaine-Induced Coronary-Artery Constriction', New England Journal of Medicine, vol. 322, no. 17, pp. 1235-1237. https://doi.org/10.1056/NEJM199004263221714
Ambre JJ, Wilkerson RD, Fraker TD, Temesy-Armos PN, Egashira K, Morgan JP et al. Cocaine-Induced Coronary-Artery Constriction. New England Journal of Medicine. 1990 Apr 26;322(17):1235-1237. https://doi.org/10.1056/NEJM199004263221714
Ambre, John J. ; Wilkerson, R. Douglas ; Fraker, Theodore D. ; Temesy-Armos, Peter N. ; Egashira, Kensuke ; Morgan, James P. ; Cregler, Louis L. ; Folev, Anthony E. ; Lange, Richard A. ; Cigarroa, Ricardo G. ; Hillis, L. David. / Cocaine-Induced Coronary-Artery Constriction. In: New England Journal of Medicine. 1990 ; Vol. 322, No. 17. pp. 1235-1237.
@article{0e9485aabb7d4d11ad8f464c8e532996,
title = "Cocaine-Induced Coronary-Artery Constriction",
abstract = "To the Editor: The conclusion of Lange et al. (Dec. 7 issue)1 from their study of cocaine-induced coronary-artery constriction implies that they know the shape of the cocaine dose–response curve for cardiac effects. They used doses of 110 to 210 mg intranasally (which are only about 30 percent bioavailable2) and produced cocaine concentrations of 30 to 220 ng per milliliter. We have acquired noninvasive and clinical cardiac data in 30 studies of intravenous cocaine users at plasma cocaine concentrations in the range produced by recreational use. In addition to five subjects receiving 30 mg of cocaine by intravenous injection,.",
author = "Ambre, {John J.} and Wilkerson, {R. Douglas} and Fraker, {Theodore D.} and Temesy-Armos, {Peter N.} and Kensuke Egashira and Morgan, {James P.} and Cregler, {Louis L.} and Folev, {Anthony E.} and Lange, {Richard A.} and Cigarroa, {Ricardo G.} and Hillis, {L. David}",
year = "1990",
month = "4",
day = "26",
doi = "10.1056/NEJM199004263221714",
language = "English",
volume = "322",
pages = "1235--1237",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "17",

}

TY - JOUR

T1 - Cocaine-Induced Coronary-Artery Constriction

AU - Ambre, John J.

AU - Wilkerson, R. Douglas

AU - Fraker, Theodore D.

AU - Temesy-Armos, Peter N.

AU - Egashira, Kensuke

AU - Morgan, James P.

AU - Cregler, Louis L.

AU - Folev, Anthony E.

AU - Lange, Richard A.

AU - Cigarroa, Ricardo G.

AU - Hillis, L. David

PY - 1990/4/26

Y1 - 1990/4/26

N2 - To the Editor: The conclusion of Lange et al. (Dec. 7 issue)1 from their study of cocaine-induced coronary-artery constriction implies that they know the shape of the cocaine dose–response curve for cardiac effects. They used doses of 110 to 210 mg intranasally (which are only about 30 percent bioavailable2) and produced cocaine concentrations of 30 to 220 ng per milliliter. We have acquired noninvasive and clinical cardiac data in 30 studies of intravenous cocaine users at plasma cocaine concentrations in the range produced by recreational use. In addition to five subjects receiving 30 mg of cocaine by intravenous injection,.

AB - To the Editor: The conclusion of Lange et al. (Dec. 7 issue)1 from their study of cocaine-induced coronary-artery constriction implies that they know the shape of the cocaine dose–response curve for cardiac effects. They used doses of 110 to 210 mg intranasally (which are only about 30 percent bioavailable2) and produced cocaine concentrations of 30 to 220 ng per milliliter. We have acquired noninvasive and clinical cardiac data in 30 studies of intravenous cocaine users at plasma cocaine concentrations in the range produced by recreational use. In addition to five subjects receiving 30 mg of cocaine by intravenous injection,.

UR - http://www.scopus.com/inward/record.url?scp=0025220657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025220657&partnerID=8YFLogxK

U2 - 10.1056/NEJM199004263221714

DO - 10.1056/NEJM199004263221714

M3 - Letter

VL - 322

SP - 1235

EP - 1237

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 17

ER -